Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Characterization of Residual Impurities in Gene Therapy Drug Products Jessica Townsend, at Intellia Therapeutics Eric S. Bishop, at Cygnus Technologies Characterization of residual impurities for gene therapy drug products is particularly challenging due to the complex nature of the final products as ... 4 months ago | 84 mins Monitoring Impurities in Biologics Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia The complexity of biotherapeutic products and their manufacturing processes can yield a variety of impurities, which must be monitored and controlled ... 3 years ago | 59 mins Characterization of Biotherapeutics Diane McCarthy, PhD, Senior Scientific Liaison, US Pharmacopeia and Kai Scheffler Product Manager at Thermo Fisher Scientific By Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia Biotherapeutic products are typically characterized by multiple ... 4 years ago | 76 mins Monitoring Impurities in Biologics Diane McCarthy, PhD, Senior Scientific Liaison, Global Biologics, US Pharmacopeia The complexity of biotherapeutic products and their manufacturing processes can yield a variety of impurities, which must be monitored and controlled ... 4 years ago | 60 mins Advances in the Purification of Antisense Oligonucleotides Robert Gronke, Ph.D., Senior Principal Scientist, at Biogen and John Cyganowski, Director of Customer Application, Merck Following on the commercial success of Spinraza® (the first successful treatment for patients with spinal muscular atrophy), antisense oligonucleotide... 2 years ago | 61 mins
